Translational control during stage conversion of Toxoplasma, an opportunistic infection of HIV/AIDS

弓形虫(HIV/AIDS 的一种机会性感染)阶段转换过程中的转化控制

基本信息

项目摘要

 DESCRIPTION (provided by applicant): This proposal addresses molecular mechanisms that are central for formation and reactivation of latent stages of Toxoplasma gondii, a protozoan parasite that causes life-threatening opportunistic infection in AIDS/HIV patients. The ability of Toxoplasma to convert from its proliferative stage (tachyzoite) to latent tissue cysts (bradyzoite) gives rise to the life-threatening chronic opportunistic disease that afflicts AIDS patients. There is a vital need for new approaches for treatment of AIDS-toxoplasmosis, but this effort has been hindered by an insufficient understanding of the mechanisms by which the latent stage develops and reactivates. We discovered that phosphorylation of the Toxoplasma alpha subunit of eukaryotic initiation factor-2 (TgIF2α) contributes to bradyzoite development. Using polysome profiling, which we adapted for use in Toxoplasma, we showed that TgIF2α phosphorylation leads to preferential translation of a subset of mRNAs that are linked to bradyzoite development. Further support that translational control has critical functions during both replicative and lateny stages comes from our new studies using the drugs salubrinal (SAL) and guanabenz (GA), which inhibit TgIF2α dephosphorylation and block the reactivation of bradyzoites. Here we show that GA also protects mice acutely infected with Toxoplasma and decreases the number of cysts in chronically infected mice. Together, our genetic, biochemical, and pharmacological experiments support our hypothesis that translational control mediated by TgIF2α phosphorylation is critical for parasite stage interconversion. Our proposed experiments will address this hypothesis and 1) establish how TgIF2α kinases coordinate conversion to bradyzoites, 2) identify translationally controlled mRNAs initiating bradyzoite development and reconversion into replicating tachyzoites, and 3) determine the mechanisms underlying TgIF2α dephosphorylation and reactivation of infection. Completion of these aims will help define the mechanics of Toxoplasma stage conversion, with an eye towards developing critically needed novel therapies for AIDS-toxoplasmosis.
 描述(由申请人提供):该提案阐述了弓形虫潜伏期形成和重新激活的核心分子机制,弓形虫是一种原生动物寄生虫,可导致艾滋病/艾滋病毒患者发生危及生命的机会性感染。增殖期(速殖子)到潜伏组织囊肿(缓殖子) 引起威胁生命的慢性机会性疾病,困扰艾滋病患者。 迫切需要治疗艾滋病弓形虫病的新方法,但由于对潜伏期发展和重新激活的机制了解不够,这一努力受到阻碍。我们发现真核起始因子弓形虫α亚基的磷酸化。 2 (TgIF2α) 有助于缓殖子的发育。使用我们在弓形虫中使用的多核糖体分析,我们发现 TgIF2α磷酸化导致与缓殖子发育相关的一部分 mRNA 的优先翻译,这一点来自我们使用药物 salubrinal (SAL) 和 guanabenz (GA) 的新研究,进一步证明翻译控制在复制阶段和潜伏阶段都具有关键功能。抑制 TgIF2α 去磷酸化并阻止缓殖子的重新激活在此我们表明 GA 还可以保护急性弓形虫感染的小鼠并减少包囊数量。我们的遗传、生化和逻辑药理学实验共同支持了我们的假设,即 TgIF2α 磷酸化介导的翻译控制对于寄生虫阶段的相互转化至关重要,我们提出的实验将解决这一假设,并 1) 确定 TgIF2α 激酶如何协调转化。缓殖子,2) 识别翻译控制的 mRNA,启动缓殖子发育并重新转化为复制速殖子,3) 确定 TgIF2α 的潜在机制完成这些目标将有助于确定弓形虫阶段转换的机制,并着眼于开发艾滋病弓形虫病急需的新疗法。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

William J Sullivan其他文献

William J Sullivan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('William J Sullivan', 18)}}的其他基金

m6A mRNA reader proteins in the AIDS-opportunistic pathogen Toxoplasma gondii
艾滋病机会致病菌弓形虫中的 m6A mRNA 阅读器蛋白
  • 批准号:
    10615374
  • 财政年份:
    2023
  • 资助金额:
    $ 38.91万
  • 项目类别:
Translation initiation factors driving persistence of Toxoplasma gondii bradyzoites in neurons
驱动弓形虫缓殖子在神经元中持续存在的翻译起始因子
  • 批准号:
    10556561
  • 财政年份:
    2022
  • 资助金额:
    $ 38.91万
  • 项目类别:
Regulation of cyst formation in the AIDS opportunistic pathogen Toxoplasma
艾滋病机会病原体弓形虫包囊形成的调节
  • 批准号:
    10515665
  • 财政年份:
    2021
  • 资助金额:
    $ 38.91万
  • 项目类别:
Regulation of cyst formation in the AIDS opportunistic pathogen Toxoplasma
艾滋病机会病原体弓形虫包囊形成的调节
  • 批准号:
    10401525
  • 财政年份:
    2021
  • 资助金额:
    $ 38.91万
  • 项目类别:
Eradicating latent toxoplasmosis
根除潜伏弓形虫病
  • 批准号:
    10116280
  • 财政年份:
    2020
  • 资助金额:
    $ 38.91万
  • 项目类别:
Epitranscriptomics in the AIDS-opportunistic pathogen Toxoplasma gondii
艾滋病机会致病菌弓形虫的表观转录组学
  • 批准号:
    9763130
  • 财政年份:
    2019
  • 资助金额:
    $ 38.91万
  • 项目类别:
Epitranscriptomics in the AIDS-opportunistic pathogen Toxoplasma gondii
艾滋病机会致病菌弓形虫的表观转录组学
  • 批准号:
    9889878
  • 财政年份:
    2019
  • 资助金额:
    $ 38.91万
  • 项目类别:
Translational Control of Encystation in the Entamoebae
内阿米巴包囊的翻译控制
  • 批准号:
    8913307
  • 财政年份:
    2015
  • 资助金额:
    $ 38.91万
  • 项目类别:
Inhibition of phosphatase activity as a novel treatment for chronic toxoplasmosis
抑制磷酸酶活性作为慢性弓形体病的新治疗方法
  • 批准号:
    8504211
  • 财政年份:
    2013
  • 资助金额:
    $ 38.91万
  • 项目类别:
Manipulation of host cell acetylome in AIDS opportunistic infection
艾滋病机会性感染中宿主细胞乙酰组的调控
  • 批准号:
    8604687
  • 财政年份:
    2013
  • 资助金额:
    $ 38.91万
  • 项目类别:

相似海外基金

Scientific Leadership Group Core
科学领导小组核心
  • 批准号:
    10595900
  • 财政年份:
    2023
  • 资助金额:
    $ 38.91万
  • 项目类别:
Hepatotoxic mechanisms of anti-HIV- and anti-COVID-19 drugs and substance use disorders
抗 HIV 和抗 COVID-19 药物和物质使用障碍的肝毒性机制
  • 批准号:
    10684434
  • 财政年份:
    2023
  • 资助金额:
    $ 38.91万
  • 项目类别:
Neurofunctional Mechanisms of Changes in Cognition and Motor Function in Aging with HIV and Parkinson's Disease
HIV 和帕金森病导致的衰老过程中认知和运动功能变化的神经功能机制
  • 批准号:
    10619383
  • 财政年份:
    2023
  • 资助金额:
    $ 38.91万
  • 项目类别:
The University of Miami AIDS Research Center on Mental Health and HIV/AIDS - Center for HIV & Research in Mental Health (CHARM)Research Core - Methods
迈阿密大学艾滋病心理健康和艾滋病毒/艾滋病研究中心 - Center for HIV
  • 批准号:
    10686544
  • 财政年份:
    2023
  • 资助金额:
    $ 38.91万
  • 项目类别:
Role of phospholipids in antifungal drug resistance in Cryptococcus neoformans
磷脂在新型隐球菌抗真菌药物耐药性中的作用
  • 批准号:
    10389392
  • 财政年份:
    2022
  • 资助金额:
    $ 38.91万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了